REGENERON PHARMACEUTICALS, INC. (REGN)
Nasdaq · Pharmaceutical Preparations · Inc. NY
What they're doing
Between 2026-08-09 and 2026-11-07, public records show 16 signals for REGENERON PHARMACEUTICALS, INC.. Most notable: 2026-09-25: Won $277.8M federal contract action from Department of Health and Human Services; 2026-09-30: Filed 8-K disclosing director or officer change; 2026-10-06: Filed 8-K disclosing material agreement. Federal contract obligations over the last 24 months total $277,052,535. This summary was assembled automatically from SEC EDGAR, USAspending.gov, U.S. Senate lobbying disclosures and Wikimedia pageview counts.
Generated 2026-11-07 from public records.
Signals, last 12 months
- Large insider salePitofsky Jason (officer) sold $1.1M of stock
- Large insider saleZoghbi Huda Y (director) sold $6.7M of stock
- Large insider saleSING GEORGE L (director) sold $6.8M of stock
- Large insider saleSING GEORGE L (director) sold $4.2M of stock
- Large insider saleLAROSA JOSEPH J (officer) sold $3.8M of stock
- Large insider salePOON CHRISTINE A (director) sold $3.1M of stock
- Large insider salePOON CHRISTINE A (director) sold $2.4M of stock
- Large insider saleSING GEORGE L (director) sold $2.6M of stock
- Large insider saleSING GEORGE L (director) sold $2.4M of stock
- Large insider saleSING GEORGE L (director) sold $1.5M of stock
- Large insider saleSING GEORGE L (director) sold $1.2M of stock
- Large insider saleSING GEORGE L (director) sold $1.0M of stock
- Large insider saleBROWN MICHAEL S (director) sold $1.7M of stock
- Material 8-K filingFiled 8-K disclosing material agreement
- Material 8-K filingFiled 8-K disclosing director or officer change
- Federal contract awardWon $277.8M federal contract action from Department of Health and Human Services
- Large insider saleBassler Bonnie L (director) sold $1.2M of stock
Insider transactions
| Date | Insider | Role | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-11-04 | Pitofsky Jason | officer | S | 179 | 950.76 | $170,186 |
| 2026-11-04 | Pitofsky Jason | officer | S | 35 | 945.61 | $33,096 |
| 2026-11-04 | Pitofsky Jason | officer | S | 108 | 944.22 | $101,976 |
| 2026-11-04 | Pitofsky Jason | officer | S | 529 | 943.53 | $499,127 |
| 2026-11-04 | Pitofsky Jason | officer | S | 1,215 | 942.31 | $1,144,907 |
| 2026-11-04 | Pitofsky Jason | officer | S | 982 | 941.58 | $924,632 |
| 2026-11-04 | Pitofsky Jason | officer | S | 575 | 940.46 | $540,765 |
| 2026-11-04 | Pitofsky Jason | officer | S | 439 | 939.57 | $412,471 |
| 2026-11-04 | Pitofsky Jason | officer | M | 905 | 492 | $445,260 |
| 2026-11-04 | Pitofsky Jason | officer | M | 1,478 | 644.54 | $952,630 |
| 2026-11-04 | Pitofsky Jason | officer | M | 1,500 | 726.53 | $1,089,795 |
| 2026-11-03 | Zoghbi Huda Y | director | S | 500 | 971.06 | $485,530 |
| 2026-11-03 | Zoghbi Huda Y | director | S | 6,939 | 970.42 | $6,733,744 |
| 2026-11-03 | Zoghbi Huda Y | director | M | 7,439 | 380.95 | $2,833,887 |
| 2026-11-03 | MURPHY ANDREW J | officer | G | 1,054 | 0 | $0 |
| 2026-11-02 | LAROSA JOSEPH J | officer | S | 527 | 966.11 | $509,140 |
| 2026-11-02 | LAROSA JOSEPH J | officer | S | 3,939 | 965.41 | $3,802,750 |
| 2026-11-02 | LAROSA JOSEPH J | officer | F | 8,686 | 950.5 | $8,256,043 |
| 2026-11-02 | LAROSA JOSEPH J | officer | M | 12,283 | 381.92 | $4,691,123 |
| 2026-11-02 | Fenimore Christopher R. | officer | G | 15 | 0 | $0 |
| 2026-11-02 | Fenimore Christopher R. | officer | F | 4,243 | 950.5 | $4,032,972 |
| 2026-11-02 | Fenimore Christopher R. | officer | M | 6,000 | 381.92 | $2,291,520 |
| 2026-11-02 | POON CHRISTINE A | director | S | 201 | 971.31 | $195,233 |
| 2026-11-02 | POON CHRISTINE A | director | S | 937 | 970.51 | $909,368 |
| 2026-11-02 | POON CHRISTINE A | director | S | 3,203 | 969.5 | $3,105,309 |
| 2026-11-02 | POON CHRISTINE A | director | S | 2,499 | 968.58 | $2,420,481 |
| 2026-11-02 | POON CHRISTINE A | director | S | 772 | 967.38 | $746,817 |
| 2026-11-02 | POON CHRISTINE A | director | S | 218 | 966.74 | $210,749 |
| 2026-11-02 | POON CHRISTINE A | director | M | 7,830 | 376.69 | $2,949,483 |
| 2026-11-02 | SING GEORGE L | director | S | 200 | 970.18 | $194,036 |
| 2026-11-02 | SING GEORGE L | director | S | 1,040 | 967.07 | $1,005,753 |
| 2026-11-02 | SING GEORGE L | director | S | 1,522 | 966.27 | $1,470,663 |
| 2026-11-02 | SING GEORGE L | director | S | 7,073 | 965.38 | $6,828,133 |
| 2026-11-02 | SING GEORGE L | director | S | 2,670 | 964.57 | $2,575,402 |
| 2026-11-02 | SING GEORGE L | director | S | 4,338 | 963.47 | $4,179,533 |
| 2026-11-02 | SING GEORGE L | director | S | 2,522 | 962.61 | $2,427,702 |
| 2026-11-02 | SING GEORGE L | director | S | 540 | 961.85 | $519,399 |
| 2026-11-02 | SING GEORGE L | director | S | 1,224 | 960.57 | $1,175,738 |
| 2026-11-02 | SING GEORGE L | director | M | 7,439 | 380.95 | $2,833,887 |
| 2026-11-02 | SING GEORGE L | director | M | 7,830 | 376.69 | $2,949,483 |
| 2026-10-30 | McCourt Marion | officer | S | 1,132 | 869.43 | $984,195 |
| 2026-10-30 | BROWN MICHAEL S | director | S | 1,929 | 875 | $1,687,875 |
| 2026-10-30 | BROWN MICHAEL S | director | M | 1,929 | 725.89 | $1,400,242 |
| 2026-10-30 | Guarini Kathryn | director | S | 400 | 900 | $360,000 |
| 2026-10-30 | Guarini Kathryn | director | M | 400 | 719.37 | $287,748 |
| 2026-10-14 | MURPHY ANDREW J | officer | S | 50 | 781.47 | $39,074 |
| 2026-10-14 | MURPHY ANDREW J | officer | S | 463 | 780.63 | $361,432 |
| 2026-10-14 | MURPHY ANDREW J | officer | S | 380 | 779.59 | $296,244 |
| 2026-10-14 | MURPHY ANDREW J | officer | S | 454 | 778.64 | $353,503 |
| 2026-10-14 | MURPHY ANDREW J | officer | S | 38 | 777.76 | $29,555 |
Federal contracts
24-month federal obligations: $277,052,535
- 2026-09-25 $277,818,931 · Department of Health and Human Services · INMAZEB EBOLA THERAPEUTICS
- 2026-09-16 $-766,396 · Department of Health and Human Services · DE-OBLIGATE CANCELING FUNDS ON OPTION 2, EXTEND POP FOR CLINS 0002 AND 0003 TO SEPT 25, 2027, ADD FINAL INDIRECT RATES A
Lobbying
No federal lobbying filings on record for this client mapping.
Public attention
7-day average 162 views/day vs 90-day median 176.